Angelo Bautista

Angelo Bautista is a Lecturer at the School of Molecular Sciences, The University of Western Australia, where he is a Doctor of Philosophy Student in Biochemistry and Molecular Biology. He holds external research roles as a Research Officer at PYC Therapeutics (2025–present) and Research Scientist at Proteomics International (2023–2025).

Education:

• Doctor of Philosophy in Biochemistry and Molecular Biology, The University of Western Australia (2020–present)
• Master of Science in Biotechnology, The University of Western Australia (2019)
• Bachelor of Science in Biochemistry, University of the Philippines (2016)

Research Interests: His work focuses on inflammation, biomarkers, and oxidative stress in diseases like Duchenne Muscular Dystrophy, with expertise in proteomics and protein post-translational modifications. His collaborations span pharmacology, biochemistry, and biomedical science.

• Key areas include reactive oxygen species, albumin oxidation, and dystrophic disease modulation.

Publications: His recent articles on oxidative stress in muscular dystrophy models and antenatal therapies highlight trends in pharmacological interventions and biomarker validation.